Susquehanna International Group
TNDM icon

Susquehanna International Group’s Tandem Diabetes Care TNDM Stock Holding History

Susquehanna International Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
108,900
+6,700
+7% +$146K ﹤0.01% 6094
2025
Q4 		$2.25M Sell
102,200
-12,900
-11% -$233K ﹤0.01% 5406
2025
Q3 		$1.4M Buy
115,100
+89,400
+348% +$1.21M ﹤0.01% 6560
2025
Q2 		$479K Sell
25,700
-30,200
-54% -$598K ﹤0.01% 9273
2025
Q1 		$1.07M Sell
55,900
-27,500
-33% -$805K ﹤0.01% 7092
2024
Q4 		$3M Buy
83,400
+16,600
+25% +$562K ﹤0.01% 4475
2024
Q3 		$2.83M Sell
66,800
-62,600
-48% -$2.65M ﹤0.01% 4652
2024
Q2 		$5.21M Buy
129,400
+5,100
+4% +$213K ﹤0.01% 3373
2024
Q1 		$4.4M Sell
124,300
-27,800
-18% -$745K ﹤0.01% 3839
2023
Q4 		$4.5M Buy
152,100
+1,200
+0.8% +$24.9K ﹤0.01% 3880
2023
Q3 		$3.13M Buy
150,900
+89,300
+145% +$2.45M ﹤0.01% 4299
2023
Q2 		$1.51M Buy
61,600
+39,900
+184% +$1.28M ﹤0.01% 5752
2023
Q1 		$881K Buy
+21,700
New +$898K ﹤0.01% 7149
2022
Q4 		– Sell
-101,800
Closed -$4.87M – 13677
2022
Q3 		$4.87M Buy
101,800
+53,600
+111% +$2.94M ﹤0.01% 3192
2022
Q2 		$2.85M Sell
48,200
-7,200
-13% -$591K ﹤0.01% 4176
2022
Q1 		$6.44M Sell
55,400
-74,000
-57% -$8.64M ﹤0.01% 3229
2021
Q4 		$19.5M Sell
129,400
-60,000
-32% -$8.1M ﹤0.01% 1879
2021
Q3 		$22.6M Buy
189,400
+76,900
+68% +$8.47M ﹤0.01% 1849
2021
Q2 		$11M Buy
112,500
+1,700
+2% +$152K ﹤0.01% 2779
2021
Q1 		$9.78M Sell
110,800
-14,200
-11% -$1.32M ﹤0.01% 2801
2020
Q4 		$12M Sell
125,000
-122,200
-49% -$12.6M ﹤0.01% 2286
2020
Q3 		$28.1M Sell
247,200
-6,900
-3% -$725K 0.01% 1216
2020
Q2 		$25.1M Buy
254,100
+22,300
+10% +$1.78M 0.01% 1240
2020
Q1 		$14.9M Sell
231,800
-13,600
-6% -$953K ﹤0.01% 1397
2019
Q4 		$14.6M Sell
245,400
-101,500
-29% -$6.26M ﹤0.01% 1708
2019
Q3 		$20.5M Buy
346,900
+53,900
+18% +$3.44M 0.01% 1314
2019
Q2 		$18.9M Sell
293,000
-10,500
-3% -$678K 0.01% 1319
2019
Q1 		$19.3M Buy
303,500
+76,600
+34% +$4.02M 0.01% 1224
2018
Q4 		$8.62M Sell
226,900
-216,400
-49% -$7.64M ﹤0.01% 1751
2018
Q3 		$19M Buy
443,300
+210,200
+90% +$7.34M 0.01% 1363
2018
Q2 		$5.13M Buy
+233,100
New +$2.87M ﹤0.01% 2675
2017
Q1 		– Sell
-1,820
Closed -$39K – 9949
2016
Q4 		$39K Buy
1,820
+120
+7% +$4.62K ﹤0.01% 9340
2016
Q3 		$130K Buy
1,700
+120
+8% +$8.75K ﹤0.01% 7838
2016
Q2 		$119K Buy
1,580
+380
+32% +$30.6K ﹤0.01% 7942
2016
Q1 		$105K Sell
1,200
-2,190
-65% -$192K ﹤0.01% 8408
2015
Q4 		$400K Sell
3,390
-1,910
-36% -$189K ﹤0.01% 7183
2015
Q3 		$467K Buy
+5,300
New +$617K ﹤0.01% 7254
2015
Q2 		– Sell
-3,470
Closed -$438K – 10465
2015
Q1 		$438K Buy
+3,470
New +$451K ﹤0.01% 7335

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's TNDM Position: Q1 2026 in Review

Susquehanna International Group reduced its Tandem Diabetes Care (TNDM) stake by 38% in Q1 2026, selling an estimated $1.08M and leaving 80,749 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #6795.

Susquehanna International Group first reported a position in TNDM in Q2 2014 and has held it in 33 quarters since. The position peaked at $19.4M in Q3 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Susquehanna International Group held 80,749 shares of Tandem Diabetes Care worth $1.55M as of Q1 2026.
  • Susquehanna International Group sold 49,572 Tandem Diabetes Care shares in Q1 2026, an estimated $1.08M.
  • Tandem Diabetes Care made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6795 holding.
  • Susquehanna International Group first reported a position in Tandem Diabetes Care in Q2 2014 and has held it in 33 quarters since.
  • Susquehanna International Group's Tandem Diabetes Care position peaked at $19.4M in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.